BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 9109529)

  • 1. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine.
    Kuczenski R; Segal DS
    J Neurochem; 1997 May; 68(5):2032-7. PubMed ID: 9109529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine.
    Kuczenski R; Segal DS; Cho AK; Melega W
    J Neurosci; 1995 Feb; 15(2):1308-17. PubMed ID: 7869099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine.
    Kuczenski R; Segal DS
    J Pharmacol Exp Ther; 2001 Mar; 296(3):876-83. PubMed ID: 11181919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral considerations.
    Florin SM; Kuczenski R; Segal DS
    J Pharmacol Exp Ther; 1995 Jul; 274(1):231-41. PubMed ID: 7616403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic changes in sensitivity occur during the acute response to cocaine and methylphenidate.
    Kuczenski R; Segal DS
    Psychopharmacology (Berl); 1999 Nov; 147(1):96-103. PubMed ID: 10591874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional norepinephrine response to amphetamine using dialysis: comparison with caudate dopamine.
    Kuczenski R; Segal DS
    Synapse; 1992 Jun; 11(2):164-9. PubMed ID: 1626314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escalating dose-binge treatment with methylphenidate: role of serotonin in the emergent behavioral profile.
    Segal DS; Kuczenski R
    J Pharmacol Exp Ther; 1999 Oct; 291(1):19-30. PubMed ID: 10490882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment.
    Florin SM; Kuczenski R; Segal DS
    Brain Res; 1994 Aug; 654(1):53-62. PubMed ID: 7982098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of l-ephedrine neurotoxicity with respect to hyperthermia and caudate/putamen microdialysate levels of ephedrine, dopamine, serotonin, and glutamate.
    Bowyer JF; Newport GD; Slikker W; Gough B; Ferguson SA; Tor-Agbidye J
    Toxicol Sci; 2000 May; 55(1):133-42. PubMed ID: 10788568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics.
    Segal DS; Kuczenski R
    J Neurosci; 1997 Apr; 17(7):2551-66. PubMed ID: 9065515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex.
    Berridge CW; Stalnaker TA
    Synapse; 2002 Dec; 46(3):140-9. PubMed ID: 12325041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escalating dose-binge stimulant exposure: relationship between emergent behavioral profile and differential caudate-putamen and nucleus accumbens dopamine responses.
    Segal DS; Kuczenski R
    Psychopharmacology (Berl); 1999 Feb; 142(2):182-92. PubMed ID: 10102771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic infusion of amphetamine increases serotonin, dopamine and norepinephrine.
    Parada M; Hernandez L; Schwartz D; Hoebel BG
    Physiol Behav; 1988; 44(4-5):607-10. PubMed ID: 2853386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat.
    Mazei MS; Pluto CP; Kirkbride B; Pehek EA
    Brain Res; 2002 May; 936(1-2):58-67. PubMed ID: 11988230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen.
    Hurd YL; Ungerstedt U
    Eur J Pharmacol; 1989 Jul; 166(2):251-60. PubMed ID: 2477259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular dopamine and amphetamine after systemic amphetamine administration: comparison to the behavioral response.
    Kuczenski R; Melega WP; Cho AK; Segal DS
    J Pharmacol Exp Ther; 1997 Aug; 282(2):591-6. PubMed ID: 9262319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine.
    Taylor D; Ho BT
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):67-75. PubMed ID: 684280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of amphetamine, methylphenidate, and apomorphine on regional brain serotonin and 5-hydroxyindole acetic acid.
    Kuczenski R; Segal DS; Leith NJ; Applegate CD
    Psychopharmacology (Berl); 1987; 93(3):329-35. PubMed ID: 2448842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.
    Ruocco LA; Carnevale UA; Treno C; Sadile AG; Melisi D; Arra C; Ibba M; Schirru C; Carboni E
    Behav Brain Res; 2010 Jun; 210(1):99-106. PubMed ID: 20156489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of amphetamine-induced changes in dopamine and 5-HT by a 5-HT(6) receptor antagonist.
    Dawson LA; Nguyen HQ; Li P
    Brain Res Bull; 2003 Feb; 59(6):513-21. PubMed ID: 12576149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.